Literature DB >> 12388806

Natural killer cell activation after infection with lactate dehydrogenase-elevating virus.

Dominique Markine-Goriaynoff1, Xavier Hulhoven1, César L Cambiaso1, Philippe Monteyne1, Thérèse Briet1, Maria-Dolores Gonzalez1, Pierre Coulie1, Jean-Paul Coutelier1.   

Abstract

Early after infection, lactate dehydrogenase-elevating virus (LDV) alters the immune system by polyclonally activating B lymphocytes, which leads to IgG2a-restricted hypergammaglobulinaemia, and by suppressing the secretion of Th2 cytokines. Considering that these alterations may involve cells of the innate immune system and cytokines such as interferon-gamma (IFN-gamma), we analysed the effect of LDV on natural killer (NK) cells. Within a few days of infection, a strong and transient NK cell activation, characterized by enhanced IFN-gamma message expression and cytolysis, was observed. LDV triggered a large increase in serum IFN-gamma levels. Because NK cells and IFN-gamma may participate in the defence against virus infection, we analysed their possible role in the control of LDV titres with a new agglutination assay. Our results indicate that neither the activation of NK cells nor the IFN-gamma secretion affect the early and rapid virus replication that follows LDV inoculation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388806     DOI: 10.1099/0022-1317-83-11-2709

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  IFN type I and type II independent enhancement of B cell TLR7 expression by natural killer cells.

Authors:  Suwan Sinha; Yuhong Guo; Suwannee Thet; Dorothy Yuan
Journal:  J Leukoc Biol       Date:  2012-05-25       Impact factor: 4.962

2.  Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus.

Authors:  Shelly J Robertson; Christoph G Ammann; Ronald J Messer; Aaron B Carmody; Lara Myers; Ulf Dittmer; Savita Nair; Nicole Gerlach; Leonard H Evans; William A Cafruny; Kim J Hasenkrug
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

3.  CD66a (CEACAM1) expression by mouse natural killer cells.

Authors:  Gaëtan Thirion; Ana Agusti Feliu; Jean-Paul Coutelier
Journal:  Immunology       Date:  2008-05-17       Impact factor: 7.397

4.  Multiplex fluorescent immunoassay for detection of mice infected with lactate dehydrogenase elevating virus.

Authors:  Veronica Adams; Matthew H Myles
Journal:  J Am Assoc Lab Anim Sci       Date:  2013       Impact factor: 1.232

5.  A requirement for FcγR in antibody-mediated bacterial toxin neutralization.

Authors:  Nareen Abboud; Siu-Kei Chow; Carolyn Saylor; Alena Janda; Jeffery V Ravetch; Matthew D Scharff; Arturo Casadevall
Journal:  J Exp Med       Date:  2010-10-04       Impact factor: 14.307

Review 6.  Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity.

Authors:  Ulf Dittmer; Kathrin Sutter; George Kassiotis; Gennadiy Zelinskyy; Zoltán Bánki; Heribert Stoiber; Mario L Santiago; Kim J Hasenkrug
Journal:  FEMS Microbiol Rev       Date:  2019-09-01       Impact factor: 16.408

Review 7.  Enhancement of autoantibody pathogenicity by viral infections in mouse models of anemia and thrombocytopenia.

Authors:  Andrei Musaji; Mory Meite; Laurent Detalle; Stéphanie Franquin; Françoise Cormont; Véronique Préat; Shozo Izui; Jean-Paul Coutelier
Journal:  Autoimmun Rev       Date:  2004-12-14       Impact factor: 9.754

8.  Gamma-interferon involvement in the pathogenesis of lactate dehydrogenase-elevating virus infection.

Authors:  Andrei Musaji; Dominique Markine-Goriaynoff; Stéphanie Franquin; Gaëtan Thirion; Thao Le Thi Phuong; Jean-Paul Coutelier
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

9.  Lactate dehydrogenase-elevating virus enhances natural killer cell-mediated immunosurveillance of mouse mesothelioma development.

Authors:  Mohamed F Mandour; Pyone Pyone Soe; Catherine Uyttenhove; Jacques Van Snick; Etienne Marbaix; Jean-Paul Coutelier
Journal:  Infect Agent Cancer       Date:  2020-05-07       Impact factor: 2.965

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.